Novel variants of unknown significance in the PMS2 gene identified in patients with hereditary colon cancer

Raffaella Liccardo,1 Carlo Della Ragione,2 Nunzio Mitilini,2 Marina De Rosa,1 Paola Izzo,1 Francesca Duraturo11Department of Molecular Medicine and Medical Biotechnologies, School of Medicine, University of Naples “Federico II”, Naples, Italy; 2UOC Pathological Anatomy, AORN &...

Full description

Bibliographic Details
Main Authors: Liccardo R, Della Ragione C, Mitilini N, De Rosa M, Izzo P, Duraturo F
Format: Article
Language:English
Published: Dove Medical Press 2019-07-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/novel-variants-of-unknown-significance-in-the-pms2-gene-identified-in--peer-reviewed-article-CMAR
id doaj-840dd6d16bb24fdfa7e4a90038016f7d
record_format Article
spelling doaj-840dd6d16bb24fdfa7e4a90038016f7d2020-11-24T21:28:26ZengDove Medical PressCancer Management and Research1179-13222019-07-01Volume 116719672547232Novel variants of unknown significance in the PMS2 gene identified in patients with hereditary colon cancerLiccardo RDella Ragione CMitilini NDe Rosa MIzzo PDuraturo FRaffaella Liccardo,1 Carlo Della Ragione,2 Nunzio Mitilini,2 Marina De Rosa,1 Paola Izzo,1 Francesca Duraturo11Department of Molecular Medicine and Medical Biotechnologies, School of Medicine, University of Naples “Federico II”, Naples, Italy; 2UOC Pathological Anatomy, AORN “A. Cardarelli”, Naples, ItalyBackground: Lynch syndrome is associated with genetic variants in mismatch repair (MMR) genes. Pathogenic variants in the MLH1 and MSH2 genes occur in most families in which the phenotype is highly penetrant. These testing criteria are likely to miss individuals with Lynch syndrome due to the less penetrant MMR genes, such as MSH6, MLH3, MSH3, and PMS2. So far, several mutations in the PMS2 gene have been described as responsible for the clinical manifestation of Lynch syndrome. Recent data have reported that families with atypical Lynch phenotype were found to have primarily monoallelic mutations in the PMS2 gene.Methods: We analyzed the PMS2 gene to detect mutations in members of 64 Lynch syndrome families by direct sequencing.Results: We report the identification of several genetic variants in patients with LS, of which three are novel variants. The carriers of these novel variants were also carried of other variants in PMS2 gene and/or in other MMR genes.Conclusion: Therefore, we think that these novel PMS2 variants may act in additive manner to manifestation LS phenotype.Keywords: Lynch syndrome, PMS2 gene, MMR genes, PMS2 variants, synergist effect of MMR variantshttps://www.dovepress.com/novel-variants-of-unknown-significance-in-the-pms2-gene-identified-in--peer-reviewed-article-CMARLynch syndromePMS2 geneMMR genesPMS2 variantssynergist effect of MMR variants
collection DOAJ
language English
format Article
sources DOAJ
author Liccardo R
Della Ragione C
Mitilini N
De Rosa M
Izzo P
Duraturo F
spellingShingle Liccardo R
Della Ragione C
Mitilini N
De Rosa M
Izzo P
Duraturo F
Novel variants of unknown significance in the PMS2 gene identified in patients with hereditary colon cancer
Cancer Management and Research
Lynch syndrome
PMS2 gene
MMR genes
PMS2 variants
synergist effect of MMR variants
author_facet Liccardo R
Della Ragione C
Mitilini N
De Rosa M
Izzo P
Duraturo F
author_sort Liccardo R
title Novel variants of unknown significance in the PMS2 gene identified in patients with hereditary colon cancer
title_short Novel variants of unknown significance in the PMS2 gene identified in patients with hereditary colon cancer
title_full Novel variants of unknown significance in the PMS2 gene identified in patients with hereditary colon cancer
title_fullStr Novel variants of unknown significance in the PMS2 gene identified in patients with hereditary colon cancer
title_full_unstemmed Novel variants of unknown significance in the PMS2 gene identified in patients with hereditary colon cancer
title_sort novel variants of unknown significance in the pms2 gene identified in patients with hereditary colon cancer
publisher Dove Medical Press
series Cancer Management and Research
issn 1179-1322
publishDate 2019-07-01
description Raffaella Liccardo,1 Carlo Della Ragione,2 Nunzio Mitilini,2 Marina De Rosa,1 Paola Izzo,1 Francesca Duraturo11Department of Molecular Medicine and Medical Biotechnologies, School of Medicine, University of Naples “Federico II”, Naples, Italy; 2UOC Pathological Anatomy, AORN “A. Cardarelli”, Naples, ItalyBackground: Lynch syndrome is associated with genetic variants in mismatch repair (MMR) genes. Pathogenic variants in the MLH1 and MSH2 genes occur in most families in which the phenotype is highly penetrant. These testing criteria are likely to miss individuals with Lynch syndrome due to the less penetrant MMR genes, such as MSH6, MLH3, MSH3, and PMS2. So far, several mutations in the PMS2 gene have been described as responsible for the clinical manifestation of Lynch syndrome. Recent data have reported that families with atypical Lynch phenotype were found to have primarily monoallelic mutations in the PMS2 gene.Methods: We analyzed the PMS2 gene to detect mutations in members of 64 Lynch syndrome families by direct sequencing.Results: We report the identification of several genetic variants in patients with LS, of which three are novel variants. The carriers of these novel variants were also carried of other variants in PMS2 gene and/or in other MMR genes.Conclusion: Therefore, we think that these novel PMS2 variants may act in additive manner to manifestation LS phenotype.Keywords: Lynch syndrome, PMS2 gene, MMR genes, PMS2 variants, synergist effect of MMR variants
topic Lynch syndrome
PMS2 gene
MMR genes
PMS2 variants
synergist effect of MMR variants
url https://www.dovepress.com/novel-variants-of-unknown-significance-in-the-pms2-gene-identified-in--peer-reviewed-article-CMAR
work_keys_str_mv AT liccardor novelvariantsofunknownsignificanceinthepms2geneidentifiedinpatientswithhereditarycoloncancer
AT dellaragionec novelvariantsofunknownsignificanceinthepms2geneidentifiedinpatientswithhereditarycoloncancer
AT mitilinin novelvariantsofunknownsignificanceinthepms2geneidentifiedinpatientswithhereditarycoloncancer
AT derosam novelvariantsofunknownsignificanceinthepms2geneidentifiedinpatientswithhereditarycoloncancer
AT izzop novelvariantsofunknownsignificanceinthepms2geneidentifiedinpatientswithhereditarycoloncancer
AT duraturof novelvariantsofunknownsignificanceinthepms2geneidentifiedinpatientswithhereditarycoloncancer
_version_ 1725970422278651904